Semaglutide Injection: Incorrect Pen in Package

Product Semaglutide Injection Issue Health products - Packaging What to do Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.

The affected lot contains a 4 mg pen but is labelled as a 2 mg pen.

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

RA-82477